Brainsway (BRSYF) Consolidated Net Income (2018 - 2026)
Brainsway's (BRSYF) quarterly Consolidated Net Income came in at $2.7 million in Q2 2026, up 33.7% on a YoY basis from $2.0 million in Q2 2025, and up 18.34% quarter-over-quarter from $2.3 million in Q1 2026.
Analysis
Brainsway (BRSYF) Consolidated Net Income (2018 - 2026) Analysis & Trends
Brainsway (BRSYF) has reported Consolidated Net Income for 9 consecutive years, with $2.7 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Consolidated Net Income rose 33.7% year-over-year to $2.7 million; the trailing twelve-month figure through Jun 2026 stood at $9.5 million (up 77.75% YoY), and the FY2025 full-year result was $7.6 million, up 159.33% from the prior year.
- Consolidated Net Income grew to $2.7 million in Q2 2026 per BRSYF's latest filing, from $2.3 million in the prior quarter.
- Across five years, Consolidated Net Income topped out at $2.9 million in Q4 2025 and bottomed at -$5.0 million in Q3 2022.
- Historically, Consolidated Net Income has averaged -$110666.7 across 5 years, with a median of $363500.0 in 2023.
- The sharpest annual moves came in 2022 and 2024: Consolidated Net Income sank 187.08% in 2022, then jumped 1118.9% in 2024.
- Over 5 years, Consolidated Net Income stood at -$3.9 million in 2022, then jumped by 103.28% to $127000.0 in 2023, then surged by 1118.9% to $1.5 million in 2024, then soared by 89.47% to $2.9 million in 2025, then decreased by 7.6% to $2.7 million in 2026.
- According to Business Quant data, Consolidated Net Income over the past three periods registered $2.7 million, $2.3 million, and $2.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.40 Bn | 175.80 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 117.21 Bn | 108.39 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 105.12 Bn | 101.64 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 64.52 Bn | 63.98 Bn | 3.85 Bn | 905.00 Mn |
| 6 | Edwards Lifesciences | 49.95 Bn | 45.69 Bn | 1.35 Bn | 241.40 Mn |
| 7 | Alcon | 33.09 Bn | 31.63 Bn | 1.68 Bn | -92.00 Mn |
| 8 | Dexcom | 32.17 Bn | 30.23 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 20.75 Bn | 20.27 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Brainsway | 592.58 Mn | 529.41 Mn | 12.77 Mn | 2.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.71 Mn |
| Mar 31, 2026 | 2.29 Mn |
| Dec 31, 2025 | 2.93 Mn |
| Sep 30, 2025 | 1.57 Mn |
| Jun 30, 2025 | 2.03 Mn |
| Mar 31, 2025 | 1.11 Mn |
| Dec 31, 2024 | 1.55 Mn |
| Sep 30, 2024 | 662,000.00 |
| Jun 30, 2024 | 600,000.00 |
| Mar 31, 2024 | 111,000.00 |
| Dec 31, 2023 | 127,000.00 |
| Sep 30, 2023 | -230,000.00 |
| Jun 30, 2023 | -1.66 Mn |
| Mar 31, 2023 | -2.43 Mn |
| Dec 31, 2022 | -3.87 Mn |
| Sep 30, 2022 | -5.04 Mn |
| Jun 30, 2022 | -2.45 Mn |
| Mar 31, 2022 | -1.99 Mn |
| Dec 31, 2021 | -1.35 Mn |
| Sep 30, 2021 | -1.80 Mn |